Nikolaos Batis

Nikolaos Batis

University of Birmingham - Birmingham / United Kingdom
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4322610
person_outline Nikolaos Batis's MOST POPULAR ARTICLES
1-) Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trialH Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ...The Lancet 393 (10166), 51-60, 20196812019
2-) Acoustofluidic salivary exosome isolation: a liquid biopsy compatible approach for human papillomavirus–associated oropharyngeal cancer detectionZ Wang, F Li, J Rufo, C Chen, S Yang, L Li, J Zhang, J Cheng, Y Kim, ...The Journal of Molecular Diagnostics 22 (1), 50-59, 2020782020
3-) Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysisH Mehanna, M Taberna, C Von Buchwald, S Tous, J Brooks, M Mena, ...The Lancet Oncology 24 (3), 239-251, 2023962023
4-) Development and validation of a combined hypoxia and immune prognostic classifier for head and neck cancerJM Brooks, AN Menezes, M Ibrahim, L Archer, N Lal, CJ Bagnall, ...Clinical Cancer Research 25 (17), 5315-5328, 2019952019
5-) Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV-16 prevalence in the United Kingdom: a cross-sectional studyH Mehanna, TS Bryant, J Babrah, K Louie, JL Bryant, RJ Spruce, N Batis, ...Clinical Infectious Diseases 69 (8), 1296-1302, 2019502019